MEDP Performance Analysis - Medpace Holdings | 20.7% 12M Return
12M Return: 20.7% | +2.2% vs S&P 500 | Volatility: 42.8% | Relative Strength, Momentum & Peer Ranking
Detailed Performance Metrics Updated: 2026-09-10 03:55
| CAGR | 28.0% |
| CAGR / Max DD | 0.71 |
| CAGR / Mean DD | 1.87 |
| CAGR / Median DD | 2.10 |
| ATR % | 2.83% |
| Beta | 0.643 |
| Beta Downside | 0.182 |
| Alpha | 5.54% |
| CAPM | 8.24% |
| Current Price | 586.30 USD |
| SMA 20 Distance | +1.30% |
| SMA 50 Distance | -1.69% |
| SMA 200 Distance | -11.18% |
| RSI 14 | 48.0 |
| EMA8 Dist. Percentile | 18.2% |
| Distance to 52W High | -6.89% |
| Hurst Exponent | 0.549 |
| METRIC | MEDP | PERCENTILE RANK |
|---|---|---|
| RS IBD | 73.93 | 44.6 |
| Performance 1M | -2.68% | 33.9 |
| Performance 3M | 25.60% | 48.2 |
| Performance 6M | 22.52% | 19.6 |
| Performance 12M | 20.74% | 41.1 |
| Sharpe Ratio | 0.56 | 41.1 |
Top Performer in Life Sciences Tools & Services 5 of 28 peers
| SYMBOL | 1W | 1M | 3M |
|---|---|---|---|
| TXG | 12.19% | 14.89% | 119.97% |
| PSNL | -3.87% | 13.10% | 68.21% |
| AVTR | 4.79% | 8.38% | 50.15% |
| MRVI | -4.79% | 14.50% | 36.27% |
| CHEMM | 6.89% | 10.42% | 34.25% |
| MEDP | 0.53% | -2.68% | 25.60% |
| SYMBOL | 6M | 12M | 5Y |
|---|---|---|---|
| TXG | 221.81% | 398.44% | -56.77% |
| GNFT | 38.28% | 247.26% | 272.73% |
| PSNL | 100.98% | 204.27% | -23.15% |
| MRVI | 91.46% | 161.28% | -85.12% |
| ILMN | 64.95% | 108.72% | -53.05% |
| MEDP | 22.52% | 20.74% | 223.80% |
Overall Best Picks of Peer Group GARP Metrics
| SYMBOL | MCAP | 1M | 12M | 5Y | P/E | P/E fwd | PEG | EPS cagr |
|---|---|---|---|---|---|---|---|---|
| ILMN NASDAQ Illumina |
33.0B | 6.89% | 108.72% | -53.05% | 40.6 | 36.1 | 2.73 | 125.12% |
| MLAB NASDAQ Mesa Laboratories |
731M | 22.09% | 102.49% | -58.02% | 147 | 35.2 | 0.00 | 5.36% |
Compare MEDP vs S&P 500
| PERIOD | MEDP | S&P 500 |
|---|---|---|
| 1 Week | 0.53% | 0.08% |
| 1 Month | -2.68% | -1.38% |
| 3 Months | 25.60% | 3.71% |
| 6 Months | 22.52% | 13.00% |
| 12 Months | 20.74% | 18.53% |
| 5 Years | 223.80% | 83.66% |
FAQ
Yes, MEDP slightly outperforms the market. Over the past 12 months, MEDP returned 20.74% compared to 18.53% for the S&P 500.
MEDP has returned 20.74% over the past 12 months, including dividends. Over 3 months the return was 25.60%, and over 5 years 223.80%.
MEDP has relatively low risk with a maximum drawdown of 39.38% over the past 3 years. The average drawdown is 14.95%.
MEDP vs Sectors 12m
| SECTOR | ETF | DIFFERENCE 12M |
|---|---|---|
| Consumer Discretionary | XLY | 24.6% |
| Communication Services | XLC | 23.5% |
| Consumer Staples | XLP | 15% |
| Consumer Staples | XLP | 15% |
| Real Estate | XLRE | 13.5% |
| Financials | XLF | 12.1% |
| Materials | XLB | 5.1% |
| Industrials | XLI | 4.9% |
| Health Care | XLV | -1.6% |
| Technology | XLK | -21.6% |
| Energy | XLE | -33% |
MEDP vs Asset Classes 12m
| ASSET CLASS | ETF | DIFFERENCE 12M |
|---|---|---|
| S&P 500 | SPY | 2.2% |
| Emerging Market | EEM | -15.7% |
| Gold | GLD | 0% |
| Long-Term Bonds | TLT | 25% |
| Risk-Free Cash | SHY | 18.7% |